Pay in 4 interest-free payments of $18.75 Learn more
Ships within 48 hours · Estimated delivery Aug 5 - Aug 10
53(54):7577-7580
which play important roles in cellular differentiation
TL12-186 displays >90% inhibition of 193 kinases at a screening concentration of 1 μM
Protein Pept Lett
2015 Jan 8
Rivaroxaban (Xarelto) yl)ethane-1 2-diamine hydrochloride 53(54):7577-7580Rivaroxaban, also known as BAY 59 7939, is an oral anticoagulant invented and manufactured by Bayer; in a number of countries it is marketed as Xarelto. If approved by the United States FDA, it will be marketed by Ortho McNeil Pharmaceutical. It is the first available orally active direct factor Xa inhibitor. Rivaroxaban is well absorbed from the gut and maximum inhibition of factor Xa occurs four hours after a dose. The effects lasts 812 hours, but
US$ 120.00
US$ 132.50
US$ 31.00
US$ 31.00
US$ 31.25
US$ 149.50
US$ 117.00
US$ 60.00
US$ 130.00
US$ 50.00
US$ 71.50
US$ 70.00
US$ 31.00